Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: arnie h who wrote (1403)	10/13/1998 10:14:00 PM
From: Ed Ajootian	Read Replies (2) \| Respond to of 1491

Arnie, Any clues as to who was dumping into those massive buys? I thought the financing folks had fully shorted their interests in this company. It is mind-boggling to me that this could have 2 mm shares of volume, a ton of which was obviously on the buy side, yet only move up 3/16ths. Does anyone know when 3rd quarter results are due out? Maybe some folks are concerned that the revenue from the eye drugs has dropped off. Wondering whether we are now at the point when it would be reasonable to expect some new analyst coverage. I know the big wire houses couldn't touch a $2 stock with a ten foot pole, but what about the biotech boutiques? BTW, I've always wondered why this thread is not in the biotech forum instead of the $5 & under forum here. Query whether some biotech fans are missing out on this great sleeper just because they never look in this forum. Can someone refresh my memory on what the cash position is at this point vs. the burn rate? Thanks to all -- one of the better stock threads anywhere in cyberspace!